Bio
Dr. Pollack's research centers on translational genomics, with a major focus on prostate diseases. An original pioneer of array-based comparative genomic hybridization, his early work covered DNA copy number alterations, novel cancer genes, and transcriptional signatures in prostate and breast cancer. His more recent work leverages genomic approaches, together with gene editing and human cell/tissue models, to study benign urologic diseases including benign prostatic hyperplasia (BPH) – the noncancerous prostate enlargement in older men leading to urinary voiding problems often refractory to treatment. Other studies cover rare (neglected) cancer types including ameloblastoma and liposarcoma.
Dr. Pollack was the 2006 recipient of the American Society of Investigative Pathology Amgen Outstanding Investigator Award, a national recognition awarded for research excellence in experimental pathology to an investigator under the age of 45. He is also an Elected Member of the American Society for Clinical Investigation, and has authored over 125 research publications.
Dr. Pollack completed his undergraduate degree at Harvard College, then his MD, PhD (Biochemistry), and clinical pathology residency training at the University of California, San Francisco. Following research fellowship training in genomics at Stanford University, he joined the faculty in 2001. In addition to his research, he has served as founding Director of the Stanford Tissue Bank.
